Medicine, Genetics, and Anthropology of Tobacco: From Punishment to Biotechnological Responsibility

Medicine, Genetics, and Anthropology of Tobacco: From Punishment to Biotechnological Responsibility Mart´ın Fuertes Oliva 2025 Abstract Over the past decades, governments have intensified tobacco regulations by restricting public smoking, increasing taxation, and implementing deterrent health campaigns. While these measures have reduced smoking rates in many countries, they have failed to address the fundamental biological cause of addiction: the chemical composition of the tobacco plant itself. This article explores, from the perspectives of medicine, genetics, and anthropology, the paradox of a society that punishes consumers while allowing industries to produce unaltered, highly addictive products. It argues that the root of the tobacco problem lies not in social policy but in the seed of the plant, and that modern genetic technologies could create non-addictive or low-nicotine varieties capable of reducing global harm. The same principle could apply to other natural drugs such as cannabis, coca, or alcoholbearing plants. True medical ethics and anthropological responsibility require that biotechnology be applied not merely to heal diseases, but to transform the sources of those diseases at their biological origin. Keywords: Medicine, genetics, anthropology, tobacco, nicotine, addiction, biotechnology, public health, genetic engineering, drug policy. 1 Introduction Tobacco control policies have expanded globally since the late twentieth century. Governments have prohibited smoking in enclosed spaces, raised taxes, and displayed graphic warnings on cigarette packages. These interventions are typically justified as protecting public health and offsetting healthcare costs derived from smoking-related diseases [WHO, 2021]. 1 However, beyond these socioeconomic mechanisms lies a deeper biological question: why has the genetic structure of the tobacco plant itself remained untouched? Modern biotechnology can modify plants for pest resistance, yield, and nutrition. Yet when it comes to the most harmful plant of the industrial era, the approach remains punitive rather than preventive. 2 Medical and Genetic Context Medicine recognizes that nicotine is among the most addictive alkaloids known, acting on nicotinic acetylcholine receptors to release dopamine and reinforce dependency cycles [Benowitz, 2010]. Current pharmacological treatments—such as patches, gums, and varenicline—aim to mitigate withdrawal, not to eliminate the root cause: the chemical profile of the tobacco leaf. Genetic research has shown that the nicotine biosynthetic pathway in Nicotiana tabacum can be altered by silencing or editing genes like PMT (putrescine N-methyltransferase), which catalyzes a key step in alkaloid synthesis [Stevens et al., 2003]. Despite this, few large-scale efforts have been made to produce commercially viable low-nicotine or nonnicotine strains. The paradox is evident: governments tax and penalize the effects of addiction but do not require the industry to modify the biological source of that addiction. Biotechnology offers a direct path to harm reduction—one that has been largely ignored due to economic and political inertia. 3 Anthropological Perspective on Tobacco and Policy Anthropology reminds us that substances like tobacco are not merely biochemical agents but cultural artifacts. Their use is embedded in rituals, identities, and power structures [Goodman, 1993]. Historically, tobacco held ceremonial and social significance before becoming an industrial commodity. The modern transformation of this plant into a global addiction reflects a shift from sacred to profane, from ritual to profit. The punitive approach of contemporary policy criminalizes users rather than addressing systemic causes. Fines, taxes, and prohibitions target individual behavior while leaving intact the industrial and agricultural structures that perpetuate dependence. From an anthropological viewpoint, this inversion of responsibility reproduces social inequality: consumers bear moral and legal blame for a problem biotechnologically solvable at its 2 root. 4 Biotechnology and the Seed of Responsibility The essence of the problem lies not in the smoker’s hand but in the seed itself. Modern genome editing tools such as CRISPR-Cas9 make it technically feasible to design tobacco with reduced toxicity, lower nicotine levels, or alternative metabolic pathways [Gururani, 2020]. If governments mandated or incentivized the production of genetically optimized tobacco—plants that preserve cultural practices but minimize harm—the global burden of smoking-related diseases could decline dramatically. Such an approach aligns with the preventive philosophy of medicine: healing by design rather than by punishment. Moreover, similar logic applies to other natural substances. Cannabis could be engineered to reduce psychoactive THC while enhancing therapeutic cannabinoids; coca plants could be modified to eliminate cocaine alkaloids while preserving nutritional or industrial uses [Small, 2015]. Alcoholic fermentation sources could be redesigned to limit ethanol yield while preserving flavor and social function. The technology exists—the will does not. 5 Ethics, Governance, and Public Responsibility From a moral and political standpoint, the responsibility for harm should rest not primarily with consumers but with industries and policymakers. Just as automotive companies are required to reduce emissions, agricultural industries producing addictive or toxic substances should be legally obliged to reduce their biochemical danger through genetic innovation. Taxation and prohibition, although symbolically potent, address symptoms rather than causes. By contrast, biotechnological regulation strikes at the origin of the problem—the genome of the plant. Public funding for such initiatives would represent an investment in preventive medicine, fulfilling the human right to health recognized by the World Health Organization [WHO, 2021]. As Rifkin argues, the next industrial revolution must be biological and empathetic, guided by sustainability and public good rather than private profit [Rifkin, 2019]. Reprogramming the tobacco genome could be one of its emblematic milestones. 3 6 Conclusion The intersection of medicine, genetics, and anthropology reveals a profound ethical contradiction: society punishes the smoker but excuses the seed. True progress would not outlaw human weakness but transform its biological context. In the twenty-first century, biotechnology allows humanity to reimagine its relationship with nature—not to dominate it, but to refine it toward health and harmony. The genetic reformation of tobacco and other psychoactive plants could mark a shift from punitive control to preventive compassion, uniting medicine and anthropology in a shared ethic of responsibility. Data Availability Statement No empirical data were collected or analyzed for this article. The discussion is conceptual, based on interdisciplinary literature from medicine, genetics, and anthropology. References References World Health Organization. (2021). WHO Report on the Global Tobacco Epidemic 2021: Addressing New and Emerging Products. Geneva: WHO Press. Benowitz, N. L. (2010). Nicotine addiction. New England Journal of Medicine, 362(24), 2295–2303. Stevens, J. F., Wollenweber, E., & Ivancic, M. (2003). Genetic modification of nicotine biosynthesis in tobacco. Plant Molecular Biology, 51(6), 983–997. Goodman, J. (1993). Tobacco in History and Culture: The Anthropological Dimension. Journal of Anthropological Research, 49(4), 435–456. Gururani, M. A. (2020). CRISPR-Cas mediated genome editing in plants: Opportunities and challenges. Frontiers in Plant Science, 11, 601. Small, E. (2015). Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Botany, 93(4), 297–312. Rifkin, J. (2019). The Green New Deal: Why the Fossil Fuel Civilization Will Collapse by 2028. St. Martin’s Press. 4